3299, is a bill introduced in the U.S. House of Representatives that would streamline government decisions and provide incentives for vaccines and treatment of dangerous pathogens and diseases.

[3] Brooks and Eshoo introduced the bill in response to a report prepared in October 2015 by the Blue Ribbon Study Panel on Biodefense.

coordination and accountability among federal departments and agencies; 2) collaboration between federal and non-federal stakeholders; and 3) innovation that addresses both lingering and novel problems.The Public Health Service Act authorizes the government to spend funds on programs to prepare communities and hospitals for public health emergencies.

Specifically, HHS would need to coordinate stockpiling of countermeasures between the Biomedical Advanced Research and Development Authority (BARDA) and Centers for Disease Control and Prevention.

Additionally, the Government Accountability Office (GAO) would be required to report on programs to improve state, local, and hospital preparedness.